These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15538566)

  • 1. Refractory post-pancreatitis thrombotic thrombocytopenic purpura: response to rituximab.
    Ruiz J; Koduri PR; Valdivieso M; Shah PC
    Ann Hematol; 2005 Apr; 84(4):267-8. PubMed ID: 15538566
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.
    Chemnitz J; Draube A; Scheid C; Staib P; Schulz A; Diehl V; Söhngen D
    Am J Hematol; 2002 Oct; 71(2):105-8. PubMed ID: 12353309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.
    Patino W; Sarode R
    J Clin Apher; 2007 Feb; 22(1):17-20. PubMed ID: 17285618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura.
    Carella AM; D'Arena G; Greco MM; Nobile M; Cascavilla N
    Bone Marrow Transplant; 2008 Jun; 41(12):1063-5. PubMed ID: 18317457
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura.
    Reddy PS; Deauna-Limayo D; Cook JD; Ganguly SS; Blecke C; Bodensteiner DC; Skikne BS; Sahud MA
    Ann Hematol; 2005 Apr; 84(4):232-5. PubMed ID: 15517266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.
    Chow KV; Carroll R; Branley P; Nicholls K; Becker G; Hogan C
    Intern Med J; 2007 May; 37(5):329-32. PubMed ID: 17504282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term remission in a patient with refractory thrombotic thrombocytopenic purpura treated with rituximab and plasma exchange.
    Basquiera AL; Damonte JC; Abichaín P; Sturich AG; García JJ
    Ann Hematol; 2008 Apr; 87(4):321-3. PubMed ID: 17899079
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab in treating refractory thrombotic thrombocytopenic purpura: three case reports.
    Dalia S; McNulty B; Colvin GA
    Med Health R I; 2008 Jul; 91(7):226-8. PubMed ID: 18705225
    [No Abstract]   [Full Text] [Related]  

  • 10. Spotlight on rituximab as a new therapeutic option for dermatomyositis and thrombotic thrombocytopenic purpura.
    Ferrer E; Moral MA
    Drug News Perspect; 2006 Oct; 19(8):482-4. PubMed ID: 17160148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory thrombotic thrombocytopenic purpura following influenza vaccination.
    Dias PJ; Gopal S
    Anaesthesia; 2009 Apr; 64(4):444-6. PubMed ID: 19317713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab treatment of thrombotic thrombocytopenic purpura in the setting of connective tissue disease.
    Niewold TB; Alpert D; Scanzello CR; Paget SA
    J Rheumatol; 2006 Jun; 33(6):1194-6. PubMed ID: 16755668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful remission of thrombotic thrombocytopenic purpura with rituximab in a patient with undifferentiated connective tissue disorder.
    Gupta D; Roppelt H; Bowers B; Kunz D; Natarajan M; Gruber B
    J Clin Rheumatol; 2008 Apr; 14(2):94-6. PubMed ID: 18391679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of rituximab therapy for refractory/relapsing thrombotic thrombocytopenic purpura].
    Cui J; Zhu TN; Zou N; Chen M; Zhao YQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):116-20. PubMed ID: 23469801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab in patients with refractory thrombotic thrombocytopenic purpura.
    Sallah S; Husain A; Wan JY; Nguyen NP
    J Thromb Haemost; 2004 May; 2(5):834-6. PubMed ID: 15099292
    [No Abstract]   [Full Text] [Related]  

  • 16. Responsiveness of thrombotic thrombocytopenic purpura to rituximab and cyclophosphamide.
    Fakhouri F; Teixeira L; Delarue R; Grünfeld JP; Veyradier A
    Ann Intern Med; 2004 Feb; 140(4):314-5. PubMed ID: 14970167
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thrombotic thrombocytopenic purpura secondary to acute pancreatitis: an uncommon association].
    Senosiáin Labiano M; Alberdi Alonso JM; Lastra Andrade PM
    Gastroenterol Hepatol; 2009; 32(7):531-2. PubMed ID: 19608300
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab.
    Gallerani E; Lerch E; Romagnani E; Stathis A; Giardelli G; Zwhalen H; Marone C; Cavalli F
    Eur J Haematol; 2006 Dec; 77(6):527-9. PubMed ID: 17042766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpura.
    Benetatos L; Vassou A; Bourantas KL
    Clin Lab Haematol; 2006 Aug; 28(4):288-9. PubMed ID: 16898975
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of mitomycin-induced thrombotic thrombocytopenic purpura with rituximab.
    Onitilo AA; Engel JM; Clouse LH; Gerndt KM
    J Vasc Interv Radiol; 2009 Feb; 20(2):275-6. PubMed ID: 19054690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.